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SWGDTGenome-wide association studies (GWAS) are a powerful tool for pathogenetic studies of complex
diseases. The rich genetic information of GWAS data is mostly not fully utilized. In this study, we
developed a sliding window-based genotype dependence testing tool SWGDT. SWGDT can be applied
to GWAS data for genome-wide susceptibility gene scan utilizing known causal gene information. To
evaluate the performance of SWGDT, a real GWAS dataset of Kashin-Beck disease (KBD) was analyzed.
Immunohistochemistry was also performed to validate the relevance of identiﬁed gene with
KBD. SWGDT analysis of KBD GWAS data identiﬁed a novel candidate gene TACR1 for KBD.
Immunohistochemistry observed that the expression level of TACR1 protein in KBD articular cartilage
was signiﬁcantly higher than that in healthy articular cartilage. The real GWAS data analysis results
illustrate the performance of SWGDT for genome-wide susceptibility gene scan. SWGDT can help to
identify novel disease genes that may be missed by GWAS.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Genome-wide association studies (GWAS) are a powerful tool
for pathogenetic studies of complex diseases. In the past decades,
extensive GWAS have been carried out and successfully identiﬁed
a group of susceptibility genes for various complex diseases.
However, the disease risks explained by reported susceptibility
genes are relatively small, which is known as missing heritability.
On the other hand, the rich genetic information of GWAS data is
not fully utilized, limiting our efforts to clarify the pathogenesis
of complex diseases.
Kashin-Beck disease (KBD) is a chronic osteochondropathy with
a strong genetic component [1–3]. Recently, we conducted the ﬁrst
GWAS of KBD, and identiﬁed a novel susceptibility gene ITPR2 forKBD [4]. However, the complex genetic basis of KBD is largely
unknown. The clinical manifestations and pathologic changes of
KBD are generally similar to that of osteoarthritis (OA) [5], suggest-
ing the common genetic mechanism shared by KBD and OA. This
hypothesis is supported by previous genetic studies, which identi-
ﬁed common susceptibility genes for KBD and OA, such as TNF and
HLA-DRB1 [6–10]. Multiple GWAS of OA have been conducted by
now. They identiﬁed a set of OA-associated genes, some of which
might also contribute to the genetic susceptibility of KBD. The
GWAS results of OA provide useful information for causal gene
studies of KBD.
In this study, we developed a sliding window-based genotype
dependence testing tool, named SWGDT. SWGDT can be applied
to GWAS data for genome-wide susceptibility gene scan utilizing
known causal gene information. With SWGDT, we conducted a
genome-wide susceptibility gene scan of KBD. We identiﬁed a
novel KBD relevant gene TACR1, which has been demonstrated to
involve in the development of OA. To validate the relevance of
TACR1 with KBD, immunohistochemistry was conducted and
observed abnormal expression of TACR1 protein in the articular
cartilage of KBD and OA comparing to healthy articular cartilage.
Fig. 1. Regional P value plot of TACR1 gene. The log10 (P values) of each SNP are
plotted against chromosomal positions. The red line denotes the genotype
dependence testing results calculated by SWGDT. The black line presents the
association analysis results of TACR1 gene obtained from our previous genome-
wide association study of KBD. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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SWGDT for the susceptibility gene scan of complex diseases.
2. Approach and implementation
The principle of SWGDT is based on the fact that the risk alleles
of various disease loci are generally enriched in patients and
impoverished in healthy controls. Therefore, the genotype scores
of disease loci of different chromosomes should correlate with
each other. Genome-wide scan of the loci correlated with known
disease loci can provide clues for identifying novel susceptibility
genes. The known disease loci were used as reference loci in
SWGDT analysis. To ensure the robust of SWGDT, a sliding window
approach was applied here. Sliding window analysis is a commonly
used method for studying the properties of genetic variations. In
SWGDT, a genome region under study is ﬁrst divided into contin-
uous windows with predeﬁned sizes. A multiple-marker genotype
dependence test is then performed to detect association between
each window and target trait. Without loss of generality, the
default value of window sizes is 10 in SWGDT. For statistical test,
we suppose a sample of m cases and n controls. For the ith sliding
window with u SNPs loci, let Scasei denote the m  u genotype score
matrix of cases, and Scontroli denote the n  u genotype score matrix
of controls. Scaser and S
control
r denote the genotype score matrix of
cases and controls at known disease loci. W denotes a weighting
parameter vector, consisting of the log(P) values of reference loci.
An independence testing statistic of the ith sliding window is
deﬁned by
ITSi ¼ abs ðCovðScasei ; Scaser Þ þ CovðScontroli ; Scontrolr Þ W
 
where Cov denotes covariance. abs denotes absolute value. 10,000
permutations were conducted to obtain the null distuition of ITSi
through randomly shufﬂing the phenotypic labels of study subjects.
The signiﬁcance level of observed ITSi was calculated as the percent-
age of permutations whose ITSi were greater than the observed ITSi.
The above sliding window-based genotype independence testing is
conducted across the whole genome except for the chromosomes
containing reference loci.
We developed a program SWGDT to implement the approach
proposed by this study. SWGDT was developed by C and R
(http://www.r-project.org/) for efﬁcient data analysis. SWGDT pro-
gram, documents and illustrative examples are available at
https://sourceforge.net/projects/swgdt/ﬁles/.
3. Illustration and results
To evaluate the performance of SWGDT, a real GWAS dataset of
KBD was used here. Brieﬂy, 90 genetically unrelated grade II or III
patients with extreme KBD phenotypes were recruited from Linyou
county of Xi’an city in China. KBD was diagnosed based on the KBD
clinical diagnosis criteria of China (GB16395-1996). 1627 geneti-
cally unrelated healthy subjects recruited from Xi’an city and
Changsha city were used as healthy controls. The subjects with
genetic bone and cartilage diseases, primary OA, rheumatoid
arthritis, or a family history of articular disorders were excluded.
Genomic DNA was extracted from peripheral blood leukocytes.
Affymetrix Genome Wide Human SNP Array 6.0 (Affymetrix,
Santa Clara, CA, USA) was applied for genotyping. A logistic regres-
sion model assuming additive genetic effects was used for
genome-wide SNP association analysis. Detailed description of
experimental design and statistical analysis can be found in our
previous studies [4]. Besides ITPR2 achieving genome-wide signif-
icant level in the GWAS of KBD, we further compared the GWAS
results of KBD with that of 6 previous GWAS of OA [11–16]. 3 wellknown OA susceptibility genes also showed association signals
in the GWAS of KBD, including CHST11 at 12q23 (P value = 7.88 
104 at rs11112182), FILIP1 at 6q14 (P value = 0.009 at rs9293999)
and SENP6 at 6q13 (P value = 0.010 at rs9352237). Given the
similar clinical manifestations, pathologic changes and signiﬁcant
genetic components of KBD and OA, ITPR2, CHST11, FILIP1 and
SENP6 were used as reference loci weighted by their GWAS P
values of KBD.
Immunohistochemistry was conducted to validate the rele-
vance of identiﬁed gene with KBD. Articular cartilage specimens
were collected from one child KBD patient (male, 11 years), one
adult KBD patient (male, 57 years), one adult OA patient (male,
60 years) and one adult healthy subject (male, 55 years). The KBD
patients came from Linyou county of Xi’an city in China. The OA
patient and healthy subject came from Xi’an city in China. The sub-
jects with genetic bone and cartilage diseases and rheumatoid
arthritis had been excluded by radiologic imaging of knee and
hematoxylin and eosin (H&E) staining of articular cartilage. The
paraformaldehyde-ﬁxed articular cartilage tissues were rinsed
with phosphate buffered saline (PBS), decalciﬁed and embedded
in parafﬁn. For histochemistry, the cartilage tissue slides were
dewaxed in xylene, hydrated with graded ethanol, and stained by
hematoxylin-eosin. For immunohistochemistry, the dewaxed and
hydrated cartilage sections were treated with 3% hydrogen perox-
ide solution for 10 min, rinsed with PBS, and incubated with rabbit
polyclonal anti-TACR1 antibody (abcam, MA, UK) at 4 C overnight.
The cartilage sections were then incubated with secondary anti-
body (ZHONGSHAN golden bridge biotechnology, China) at 37 C
for 15 min, exposed to Streptavidin-Horseradish Peroxidase at
37 C for 15 min, and stained with DAB substrate kit (Vector
Laboratories, Burlingame, CA) and Meyer hematoxylin.
Across the whole genome, SWGDT analysis identiﬁed one gene
TACR1 showing the most P value = 4.74  105. Fig. 1 presents
the regional P value plot of TACR1. Consistent association
trends were observed for TACR1 in this SWGDT analysis and
previous GWAS of KBD. Within TACR1, SWGDT analysis detected
25 SNPs with P values < 0.05. The most signiﬁcant one was
rs6546975 (P value = 4.74  105). rs6546975 also presented a
P value of 4.30  103 (Odds ratio = 0.59) in the previous GWAS
of KBD (see Fig. 2).
Immunohistochemistry observed that the expression levels of
TACR1 protein in the articular cartilage of child KBD ﬁnger, adult
Fig. 2. Hematoxylin-eosin (4  10) and immunohistochemistry (40  10) images of ﬁnger articular cartilage of KBD child (A, male, 11 years), knee articular cartilage of KBD
adult (B, male, 57 years), knee articular cartilage of OA adult (C, male, 60 years) and knee articular cartilage of healthy adult (D, male, 55 years).
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the articular cartilage of adult healthy knee. These results support
the implication of TACR1 in the development of KBD.
4. Discussion
In this study, we developed a sliding window-based genotype
dependence testing approach for genome-wide scan of susceptibil-
ity gene utilizing known causal gene information. The real GWAS
data analysis results of KBD illustrate the application of SWGDT.
Because permutations are applied for evaluating the signiﬁcance
levels of testing statistics, SWGDT does not depend on speciﬁc sta-
tistical assumption. SWGDT does not suffer from the power loss
causing by multiple testing problems. SWGDT provides an alterna-
tive approach for integrating known disease gene information into
the susceptibility gene mapping of human complex diseases. Tofacilitate researchers, we also developed a program, named
SWGDT to implement the approach proposed by this study.
Using SWGDT, we also identiﬁed TACR1 as a novel susceptibil-
ity gene of KBD. TACR1 encodes tachykinin receptor 1, which
involves in inﬂammation and immunity through binding to
tachykinin substance P. Previous studies support that functional
dysfunction of TACR1 was implicated in the development of arthri-
tis. For instance, it was observed that substance P and TACR1 were
expressed in human articular cartilage, and contributed to the
maintenance of normal structure and function of articular cartilage
[17]. TACR1 antagonists inhibited cartilage destruction in rat
inﬂammatory joints [18]. In rabbit knees, interleukin-1 (IL1) and
tumor necrosis factor (TNF) could enhance the expression of sub-
stance P and accelerate cartilage degradation [19]. It is interesting
that IL1 and TNF have been found to involve in the articular
cartilage damage of KBD [6,20,21]. Given the roles of TACR1 in
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of arthritis, it is reasonable to infer that TACR1 contributed to the
joint damage of KBD. Further studies are necessary to conﬁrm
our ﬁnding.
In summary, we developed a ﬂexible tool SWGDT for
genome-wide susceptibility gene scan utilizing known causal gene
information. SWGDT may help to identify novel disease genes that
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